Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3081 of 6351
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Online mental fitness camp shows promise for pregnancy blues
Symptom relief CompletedThis study was a multi-center randomized controlled trial of an Internet-based self-help mental fitness training camp intervention that included women in early, mid, and late pregnancy with or without psychological distress. A comparison was conducted between the intervention and…
Sponsor: Fangbiao Tao • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can smarter discharge instructions help concussion patients heal faster?
Knowledge-focused By invitation onlyThe purpose of this study is to develop and validate ways to provide better patient education and clinical management for individuals who go to the emergency department (ED) with concussion or mild traumatic brain injury (mTBI).
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Kitchen spice may tame PCOS hormones, small study hints
Disease control CompletedHyperandrogenic anovulation is a common gynecological illness that impacts the ovaries, vagina and uterus. According to Statistics, in Pakistan 17.6% of individuals seeking treatment at infertility clinics were found to be affected by hyperandrogenic anovulation. Studies indicate…
Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Prostate cancer radiation in one day? new study tests faster treatment
Disease control Recruiting nowThis is a single center single arm prospective pilot study investigating the safety of high dose rate (HDR) brachytherapy as monotherapy delivered in 2 fractions 3 hours apart. HDR monotherapy has been established as safe and effective in this context, however previous studies ha…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
No-Scope cancer screening could save lives in rural oregon
Diagnosis OngoingRecent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Shockwaves could help men with ED – but not everyone
Symptom relief Recruiting nowThis is a device study (while the device has been patented and cleared by the FDA, the indication of the use for Erectile Dysfunction has been yet approve). EXSTACY is a study to collect information on which patients who have trouble getting or keeping an erection rigid enough fo…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New study to see if tezepelumab tames severe asthma in daily life
Disease control OngoingELBRUS is a 12-month (52-week), multi-centre, prospective, non-comparative and non-interventional (observational), post-reimbursement real-world evidence study that will assess patient-reported outcomes after tezepelumab treatment initiation in participants with severe asthma in …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Pumping iron for diabetes: effort matters more than you think?
Disease control CompletedIn this study the primary aims are to investigate the effect of resistance exercise training with different degrees of effort on glycemic control and psychological variables in individuals living with type 2 diabetes mellitus. As a secondary aim, investigate adherence and dropout…
Sponsor: University of New Mexico • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can cannabis ease opioid withdrawal? small study aims to find out
Symptom relief Recruiting nowThis study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Phase 1 • Sponsor: Shanna Babalonis, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Meditation app aims to boost sleep and ease stress in aging brains
Symptom relief OngoingThe goal of this proposed research is to collect pilot data to test the hypothesis that treatment with a novel form of closed-loop digital meditation (MediTrain) will lead to a greater magnitude of gains in cognitive abilities in patients with mild cognitive impairment (MCI), com…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Your phone could predict your next mood episode days in advance
Knowledge-focused Recruiting nowVeterans with bipolar disorders (BD) experience recurrent and seemingly unpredictable periods of severe impairments in psychosocial functioning, such as participation in social roles and activities. Many effective treatments for BD emphasize early detection of bipolar episodes, i…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Gene therapy for wet AMD: 4-Year safety check begins
Disease control OngoingIn neovascular (wet) age-related macular degeneration (nAMD), the macula, or the part of the eye that provides the clear, detailed central vision, is being affected by abnormal blood vessel growth and leakage. This leakage affects the vision over time and can lead to severe blurr…
Phase 1 • Sponsor: Exegenesis Bio • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Ozonated oil: a new edge for elite athletes?
Symptom relief CompletedOzonized oil has anti-inflammatory and antioxidant properties, but its effects on athletic performance remain unclear. This study evaluated whether daily ozonized oil supplementation, combined with training, influences aerobic capacity, anaerobic power, maximal strength, and musc…
Sponsor: Universita degli Studi di Genova • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New hope for endometriosis pain: exercise and education program shows promise
Symptom relief Recruiting nowThis is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program, and the co…
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Could Pain-Free exercise help PAD patients walk better?
Symptom relief Recruiting nowThis study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the Non-Ischemic Exercise (NICE) program to improve exercise and vascular outcome measures in patients with peripheral artery disease (PAD).
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Texts and videos for healthier babies: nepal tests mobile intervention
Knowledge-focused Recruiting nowGlobally, neonatal and infant mortality persist as challenging concerns, paralleled by a notable prevalence of low birth weight and preterm birth. Some of the factors contributing to these issues include poor maternal health and nutrition, maternal smoking, and insufficient mater…
Sponsor: Kathmandu University School of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could a mushroom drink fight cancer fatigue?
Symptom relief CancelledEffects of a food product containing mushroom extracts (AndoSanTM) in subjects with colorectal cancer-related fatigue. AndoSanTM is a specialized liquid food product that includes fermented extracts from the fungi Agaricus subrufesence (Agaricus blazei Murill), Hericium erinaceu…
Sponsor: Mycotech Pharma AS • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Could a single brain target treat depression, anxiety, and OCD at once?
Symptom relief CompletedThe goal of this clinical trial is to test a new brain stimulation treatment target for individuals with depression plus at least one additional psychiatric disorder. The main question is to understand the safety profile of a non-invasive form of brain stimulation called accelera…
Early phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Italy launches massive PrEP study to slash new HIV infections
Prevention Recruiting nowDespite significant advances in HIV treatment, transmission remains a public health concern. In 2022, there were 1.3 million new HIV infections worldwide and 1,888 new diagnoses in Italy, with sexual transmission being the predominant route. Many individuals are still diagnosed l…
Sponsor: Fondazione ICONA • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC